67. Polycystic kidney disease Clinical trials / Disease details

Clinical trials : 221 / Drugs : 212 - (DrugBank : 55) / Drug target genes : 40 - Drug target pathways : 151

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01223755 (ClinicalTrials.gov)	September 2010	12/10/2010	Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency	EFFECTS OF SIROLIMUS ON DISEASE PROGRESSION IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND SEVERE RENAL INSUFFICIENCY	Autosomal Dominant Polycystic Kidney Disease (ADPKD)	Drug: Sirolimus;Drug: conventional therapy	Mario Negri Institute for Pharmacological Research	NULL	Terminated	18 Years	80 Years	Both	41	Phase 2/Phase 3	Italy
2	NCT00491517 (ClinicalTrials.gov)	March 2007	25/6/2007	Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety	Sirolimus Treatment in Patients With ADPKD	Polycystic Kidney	Drug: Sirolimus;Drug: conventional therapy	Mario Negri Institute for Pharmacological Research	NULL	Completed	18 Years	80 Years	Both	22	Phase 2	Italy